Company Info
| Year Established: | 2015 |
Contacts
| Primary: | Alan Wahl, PhD CEO |
| Other: | Che-Leung Law, PhD CSO |
Company Description
Abacus Bioscience is developing a new class of immunotherapy that unleashes the power of a novel CD180 platform technolo
| Year Established: | 2015 |
| Primary: | Alan Wahl, PhD CEO |
| Other: | Che-Leung Law, PhD CSO |
Abacus Bioscience is developing a new class of immunotherapy that unleashes the power of a novel CD180 platform technolo